Budget proposal to allow Medicare to negotiate prices should 'enrage' seniors, PhRMA says

Industry lobbying association PhRMA responded with ire to the sweeping drug pricing reforms Congress is considering and President Joe Biden’s executive order last week, which encourages biosimilar and generic competition and Medicare to negotiate drug costs. The group blasted the initiatives as “an attempt to upend Medicare to help pay for Tesla tax credits and other government programs at seniors’ expense.”